Product Introduction

SITAPTIN-M50/500 TAB(15 Pcs) (available as a TAB) is high-quality and designed to target Diabetes Management issues. By combining reliable clinical efficacy with an optimized absorption profile, SITAPTIN-M50/500 TAB(15 Pcs) helps in supporting conditions and shields tissues against further physiological strain, facilitating a smoother path to recovery.

Uses of SITAPTIN-M50/500 TAB(15 Pcs)

• Delaying long-term macrovascular and microvascular diabetic complications.
• Management of insulin resistance in combination with lifestyle modifications.
• Reduction of post-prandial and fasting blood glucose excursions.

Benefits of SITAPTIN-M50/500 TAB(15 Pcs)

• Pancreatic Support: Optimizes insulin secretion or improves peripheral tissue insulin sensitivity.
• Weight & Metabolic Control: Certain classes help in managing body weight while providing cardiovascular safety benefits.
• HbA1c Reduction: Supports gradual, sustained lowering of long-term glycosylated hemoglobin levels.

Side Effects of SITAPTIN-M50/500 TAB(15 Pcs)

Common side effects may include:

• Digestive issues (nausea, flatulence, abdominal bloating, metallic taste).
• Hypoglycemia (low blood sugar) if combined with other antidiabetic agents.
• Upper respiratory tract congestion.

How to Use SITAPTIN-M50/500 TAB(15 Pcs)

• Take SITAPTIN-M50/500 TAB(15 Pcs) orally as directed by your physician.
• Swallow the tablet or capsule whole with a glass of water; do not crush or chew.
• It is usually recommended to take this medication at a fixed time each day to maintain stable blood levels.

How SITAPTIN-M50/500 TAB(15 Pcs) Works

SITAPTIN-M50/500 TAB(15 Pcs) works by improving insulin sensitivity in peripheral tissues, reducing hepatic glucose output, delaying carbohydrate absorption in the intestine, or promoting glucose excretion via the kidneys.

Safety Advice for SITAPTIN-M50/500 TAB(15 Pcs)

• Alcohol: Avoid heavy alcohol intake; it increases the risk of severe hypoglycemia and lactic acidosis.
• Pregnancy: Discontinue oral hypoglycemics and transition to insulin therapy under obstetric supervision.
• Lactation: Not recommended; seek advice on switching to insulin or alternative safe methods during nursing.
• Kidney & Liver: Renal function (eGFR) must be checked regularly; dosage adjustments are crucial in renal impairment.